WallStreetZenWallStreetZen

NASDAQ: SLS
Sellas Life Sciences Group Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their SLS stock forecasts and price targets.

Forecast return on equity

Is SLS forecast to generate an efficient return?

Company
517.08%
Industry
352.12%
Market
211.34%
SLS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SLS forecast to generate an efficient return on assets?

Company
457.65%
Industry
122.26%
SLS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SLS earnings per share forecast

What is SLS's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.32
Avg 2 year Forecast
-$0.18
Avg 3 year Forecast
$0.11

SLS revenue forecast

What is SLS's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$21.9M
Avg 2 year Forecast
$36.7M
Avg 3 year Forecast
$120.7M

SLS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SLS$3.77N/AN/A
LXEO$7.41$20.17+172.16%Strong Buy
LBRX$21.45$49.00+128.44%Strong Buy
DNA$8.97$10.50+17.06%Hold
KROS$17.91$21.00+17.25%Buy
View Top Biotech Stocks

Sellas Life Sciences Group Stock Forecast FAQ

What is SLS's earnings growth forecast for 2026-2028?

(NASDAQ: SLS) Sellas Life Sciences Group's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 69.84%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.88%.

Sellas Life Sciences Group's earnings in 2026 is -$25,942,000.On average, 4 Wall Street analysts forecast SLS's earnings for 2026 to be -$45,367,853, with the lowest SLS earnings forecast at -$52,489,965, and the highest SLS earnings forecast at -$29,912,870. On average, 4 Wall Street analysts forecast SLS's earnings for 2027 to be -$24,941,636, with the lowest SLS earnings forecast at -$36,294,282, and the highest SLS earnings forecast at -$11,965,148.

In 2028, SLS is forecast to generate $15,098,877 in earnings, with the lowest earnings forecast at -$12,563,405 and the highest earnings forecast at $44,869,305.

If you're new to stock investing, here's how to buy Sellas Life Sciences Group stock.

What is SLS's revenue growth forecast for 2026-2028?

(NASDAQ: SLS) Sellas Life Sciences Group's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 116.92%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.08%.

Sellas Life Sciences Group's revenue in 2026 is $0.On average, 3 Wall Street analysts forecast SLS's revenue for 2026 to be $3,119,057,707, with the lowest SLS revenue forecast at $3,026,327,810, and the highest SLS revenue forecast at $3,242,555,129. On average, 3 Wall Street analysts forecast SLS's revenue for 2027 to be $5,221,362,713, with the lowest SLS revenue forecast at $3,956,333,188, and the highest SLS revenue forecast at $6,617,439,097.

In 2028, SLS is forecast to generate $17,188,504,980 in revenue, with the lowest revenue forecast at $14,197,075,519 and the highest revenue forecast at $20,525,926,640.

What is SLS's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: SLS) forecast ROA is 457.65%, which is higher than the forecast US Biotechnology industry average of 122.26%.

What is SLS's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: SLS) Sellas Life Sciences Group's current Earnings Per Share (EPS) is -$0.28. On average, analysts forecast that SLS's EPS will be -$0.32 for 2026, with the lowest EPS forecast at -$0.37, and the highest EPS forecast at -$0.21. On average, analysts forecast that SLS's EPS will be -$0.18 for 2027, with the lowest EPS forecast at -$0.25, and the highest EPS forecast at -$0.08. In 2028, SLS's EPS is forecast to hit $0.11 (min: -$0.09, max: $0.32).

What is SLS's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: SLS) forecast ROE is 517.08%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.